124. The Reinforcing Efficacy of the Dopamine Reuptake Inhibitor 2β-Propanoyl-3β-(4-tolyl)-tropane (PTT) as Measured by a Progressive-Ratio Schedule and a Choice Procedure in Rhesus Monkeys

Authors: Joshua A. Lile, Drake Morgan, Anne M. Birmingham, Zhixia Wang, William L. Woolverton, Huw M. L. Davies and Michael A. Nader

J. Pharmacol. Exp. Therap., 

20023032, 640-648

Continue reading “124. The Reinforcing Efficacy of the Dopamine Reuptake Inhibitor 2β-Propanoyl-3β-(4-tolyl)-tropane (PTT) as Measured by a Progressive-Ratio Schedule and a Choice Procedure in Rhesus Monkeys”

106. Synthesis of 2β-Acyl-3β-(substituted naphthyl)-8-azabicyclo[3.2.1]octanes and Their Binding Affinities at Dopamine and Serotonin Transport Sites

Authors: Huw M. L. Davies , Vernon Gilliatt , Lisa A. Kuhn , Elie Saikali , Pingda Ren , Philip S. Hammond , Tammy Sexton  and Steven R. Childers

J. Med. Chem.,

2001, 44 (10), 1509–1515

jm0003631n00001

Continue reading “106. Synthesis of 2β-Acyl-3β-(substituted naphthyl)-8-azabicyclo[3.2.1]octanes and Their Binding Affinities at Dopamine and Serotonin Transport Sites”

103. A cocaine analog, 2β-propanoyl-3β-(4-tolyl)-tropane (PTT), reduces tyrosine hydroxylase in the mesolimbic dopamine pathway

Authors: Willard M Freeman, George J Yohrling IV, James B Daunais, Lynda Gioia, Stephanie L Hart, Linda J Porrino, Huw M.L Davies, Kent E Vrana

Drug and Alcohol Dependence

2000611, 15-21

Continue reading “103. A cocaine analog, 2β-propanoyl-3β-(4-tolyl)-tropane (PTT), reduces tyrosine hydroxylase in the mesolimbic dopamine pathway”